Agilent Technologies (A) Peer Comparison
$176.19
As on 19-Nov-2026 14:45EST
Market cap
$49,051 Mln
Revenue (TTM)
$7,372 Mln
P/E Ratio
34.1
P/B Ratio
6.6
Div. Yield
0.6 %
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
49,051 | 129,180 | 58,757 | 48,964 | 11,913 |
Revenue ($ Mln) |
7,372 | 37,542 | 19,457 | 3,458 | 4,237 |
Net Profit ($ Mln) |
1,440.00 | 5,230.00 | 1,146.00 | 1,014.77 | 570.30 |
Net Margin (%) |
19.53 | 13.93 | 5.66 | 29.34 | 13.46 |
RoE (%) |
20.18 | 10.47 | 4.58 | 13.86 | 6.83 |
Price to Earnings |
34.11 | 24.81 | 42.63 | 49.58 | 21.38 |
Price-To-Book |
6.62 | 2.59 | 2.37 | 6.64 | 1.42 |
Income Statement ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,948.00 | 33,537.00 | 20,223.00 | 2,746.62 | 4,092.40 |
|
Cost of Revenue
|
3,305.00 | 11,632.00 | 10,717.00 | 699.64 | 1,609.50 |
|
Gross Profit
|
3,643.00 | 21,905.00 | 9,924.00 | 2,046.98 | 2,482.90 |
|
Operating Expenses
|
2,164.00 | 15,950.00 | 7,124.00 | 1,355.55 | 1,800.00 |
|
Operating Profit (EBIT)
|
1,479.00 | 5,955.00 | 2,383.00 | 691.44 | 682.90 |
|
Other Income
|
-- | -- | 0.00 | -- | -- |
|
Profit before Tax
|
1,435.00 | 5,628.00 | 1,981.00 | 919.38 | 566.50 |
|
Provision for Tax
|
132.00 | 936.00 | 493.00 | 205.24 | 191.60 |
|
Profit after Tax (Net Income)
|
1,303.00 | 4,662.00 | 1,144.00 | 714.14 | 374.90 |
|
Minority Interest
|
-- | 232.00 | 0.00 | -- | 0.20 |
|
Consolidated Profit
|
1,303.00 | 4,662.00 | 382.00 | -- | -- |
Liabilities ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,741.00 | 48,024.00 | 24,682.00 | 5,832.37 | 8,238.90 |
|
Minority Interest
|
-- | 232.00 | 0.00 | -- | 0.20 |
|
Non-Current Liabilities
|
3,639.00 | 30,545.00 | 16,566.00 | 108.98 | 3,042.90 |
|
Current Liabilities
|
2,347.00 | 12,879.00 | 9,543.00 | 1,398.40 | 1,112.80 |
|
Total Liabilities
|
12,727.00 | 91,680.00 | 55,325.00 | 7,339.76 | 12,394.80 |
Assets ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
8,133.00 | 67,865.00 | 42,474.00 | 1,030.95 | 10,288.40 |
|
Current Assets
|
4,594.00 | 23,814.00 | 8,316.00 | 6,308.80 | 2,106.40 |
|
Total Assets
|
12,727.00 | 91,680.00 | 55,325.00 | 7,339.76 | 12,394.80 |
|
Total Debt*
|
3,354.00 | 28,516.00 | 16,345.00 | 75.78 | 2,783.60 |
|
Net Current Assets
|
2,247.00 | 10,935.00 | 0.00 | 4,910.40 | 993.60 |
Cashflow ($ Mln)
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,559.00 | 7,044.00 | 3,430.00 | 1,090.05 | 796.10 |
|
Cash Flow from Investing Activities
|
-394.00 | -1,937.00 | -818.00 | -700.14 | -372.90 |
|
Cash from Financing Activities
|
-715.00 | -4,361.00 | -3,617.00 | 26.12 | -425.90 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.32 | 6.14 | 3.65 | 13.46 | 3.46 |
|
ROE (%)
|
20.62 | 9.49 | 4.69 | 13.63 | 4.59 |
|
ROA (%)
|
10.61 | 5.13 | 1.86 | 10.78 | 3.03 |
|
EBIT Margin (%)
|
-- | -- | 12.36 | -- | -- |
|
Net Margin (%)
|
18.75 | 13.90 | 5.66 | 26.00 | 9.16 |
|
Cash Profit Margin (%)
|
-- | -- | 0.00 | -- | -- |
Growth Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.07 | 0.04 | -7.40 | 0.16 | 0.05 |
|
EBIT Growth (%)
|
-- | -- | 0.20 | -- | -- |
|
Net Profit Growth (%)
|
1.09 | 26.82 | -31.82 | 35.84 | -4.44 |
|
EPS Growth (%)
|
-- | -- | -28.76 | -- | -- |
|
Book Value Growth (%)
|
-- | -- | 1.85 | -- | -- |
Valuation Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | 32.03 | -- | -- |
|
Price / Book Value
|
-- | -- | 2.12 | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.85 | 2.12 | 14.54 | -5.29 | 2.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.50 | 0.59 | 0.00 | 0.01 | 0.34 |
|
Short term debt to equity ratio
|
0.05 | 0.06 | 0.12 | 0.00 | 0.01 |
|
Current Ratio
|
1.96 | 1.85 | 0.87 | 4.51 | 1.89 |
|
Quick Ratio
|
1.52 | 1.42 | 0.54 | -- | 1.13 |
|
Interest Coverage
|
13.81 | 8.72 | 4.82 | -- | 6.30 |
Operating Efficiency Ratios
| Agilent Technologies (A) | Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
21.40 | 19.43 | 13.70 | 38.49 | 20.26 |
|
Asset Turnover
|
0.57 | 0.37 | 0.33 | 0.41 | 0.33 |
|
Receivable days
|
73.89 | 68.85 | 50.40 | 129.37 | 68.99 |
|
Inventory Days
|
111.40 | 167.88 | 118.59 | 0.00 | 187.07 |
|
Payable days
|
61.34 | 76.29 | 59.32 | 16.17 | 63.64 |
|
Cash Conversion Cycle
|
123.95 | 160.44 | 109.67 | 109.59 | 192.42 |